SCHEMBL27923596

SCHEMBL27923596

Nc1ccc(C(=O)C(COCc2ccccc2)NC(=O)c2ccc3cc[nH]c3c2)c(Oc2ccccc2)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.39
TAS1R1 Q7RTX1 2/20 0.39
JAK2 O60674 1/20 0.39
LNPEP Q9UIQ6 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.37
SIRT1 Q96EB6 1/20 0.37
SIRT3 Q9NTG7 1/20 0.37
S1PR1 P21453 4/20 0.37
UGCG Q16739 2/20 0.37
GPR132 Q9UNW8 1/20 0.36
CTSS P25774 1/20 0.36
APP P05067 1/20 0.36
MAPT P10636 1/20 0.36
PADI4 Q9UM07 1/20 0.36
PADI2 Q9Y2J8 1/20 0.36
MAPK14 Q16539 1/20 0.35
BCL2L1 Q07817 1/20 0.35
F10 P00742 1/20 0.35
SMYD3 Q9H7B4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28808912 0.94 TAS1R3 (0.42) TAS1R3TAS1R1JAK2LNPEPS1PR1
SCHEMBL27923595 0.92 TAS1R3 (0.41) TAS1R3TAS1R1JAK2LNPEPSIRT2
SCHEMBL27923593 0.88 JAK2 (0.43) TAS1R3TAS1R1JAK2LNPEPSIRT2
SCHEMBL28808910 0.85 TAS1R3 (0.42) TAS1R3TAS1R1JAK2LNPEPS1PR1
SCHEMBL27923613 0.85 JAK2 (0.41) JAK2LNPEPS1PR1UGCG
SCHEMBL28808909 0.81 TAS1R3 (0.46) TAS1R3TAS1R1JAK2LNPEPS1PR1
SCHEMBL1375523 0.79 S1PR1 (0.60) TAS1R3TAS1R1JAK2SIRT2SIRT1
SCHEMBL27942618 0.76 UGCG (0.41) S1PR1UGCGCTSSBCL2L1
SCHEMBL27923611 0.76 JAK2 (0.44) JAK2LNPEPS1PR1UGCGMAPK14
SCHEMBL27923608 0.76 S1PR1 (0.47) S1PR1UGCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102245174-B Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents EXELIXIS INC 2013-11-06 CN disclosed